INTZ - Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.
Bolt Biotherapeutics posted a GAAP loss of 28 cents per share on sales of $5.30 million, according to data from Benzinga Pro.
Also, Guggenheim analyst Michael Schmidt downgraded Bolt Biotherapeutics from Buy to Neutral, while Stifel analyst Stephen Willey downgraded the stock from Buy to Hold and lowered the price target from $6 to $1.5.
Bolt Biotherapeutics shares dipped 34.4% to $0.8652 on Wednesday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- AERWINS Technologies Inc. (NASDAQ:AWIN) shares surged 201% to $8.16.
- Sintx Technologies, Inc. (NASDAQ:SINT) jumped 169% to $0.1449 after jumping over 41% on Tuesday. SINTX Technologies recently posted downbeat quarterly results.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) jumped 87% to $0.5336 after jumping around 368% on Tuesday.
- Edible Garden AG Incorporated (NASDAQ:EDBL) climbed 53.2% to $6.54 following first-quarter results.
- iPower Inc. (NASDAQ:IPW) gained 53% to $1.36 after the company reported better-than-expected third-quarter financial results.
- Selina Hospitality PLC (NASDAQ:SLNA) jumped 51% to $0.0850.
- Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) shares gained 41% to $0.0627 after surging 7% on Tuesday.
- Complete Solaria, Inc. (NASDAQ:CSLR) gained 30.6% to $0.90. Complete Solaria signed a term sheet to eliminate Carlyle debt.
- OptimizeRx Corporation (NASDAQ:OPRX) jumped 24% to $13.03 following upbeat quarterly results.
- Blue Star Foods Corp. (NASDAQ:BSFC) rose 23% to $0.0686.
- monday.com Ltd. (NASDAQ:MNDY) jumped 21.5% to $220.93 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.
- Telos Corporation (NASDAQ: